Neurocrine Biosciences Inc (NBIX)
Payables turnover
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cost of revenue (ttm) | US$ in thousands | 1,043,000 | 987,200 | 960,300 | 928,400 | 929,000 | 891,900 | 868,900 | 823,200 | 776,400 | 731,600 | 698,000 | 656,700 | 583,300 | 536,300 | 492,700 | 445,300 | 431,200 | 427,750 | 397,039 | 380,571 |
| Payables | US$ in thousands | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Payables turnover | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
December 31, 2024 calculation
Payables turnover = Cost of revenue (ttm) ÷ Payables
= $1,043,000K ÷ $—K
= —
The payables turnover ratio is used to measure how quickly a company pays its suppliers. Unfortunately, based on the data provided for Neurocrine Biosciences Inc, the payables turnover ratio is not available for any period. This could be due to the data not being disclosed or the company not disclosing specific figures necessary to calculate this ratio.
Without the specific payables turnover figures, it is difficult to analyze Neurocrine Biosciences Inc's ability to manage its payables efficiently. Payables turnover is an important metric in assessing a company's liquidity and relationship with suppliers. A higher payables turnover ratio usually indicates that a company is paying its suppliers quickly, while a lower ratio may suggest that a company is taking longer to pay its outstanding bills.
In order to provide a comprehensive analysis of Neurocrine Biosciences Inc's payables turnover, it would be necessary to have access to specific financial data for the relevant periods. Investors and analysts typically use payables turnover ratios in conjunction with other financial ratios to gain a more holistic view of a company's financial health and operational efficiency.
Peer comparison
Dec 31, 2024